Docoh
Loading...

ADMP Adamis Pharmaceuticals

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. The company was founded in June 2006 and is headquartered in San Diego, CA.

Company profile

Ticker
ADMP
Exchange
CEO
Dennis Carlo
Employees
Incorporated
Location
Fiscal year end
Former names
CELLEGY PHARMACEUTICALS INC
SEC CIK
IRS number
820429727

ADMP stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

31 Mar 21
11 Apr 21
31 Dec 21
Quarter (USD)
Sep 20 Jun 20 Mar 20 Sep 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 19 Dec 18 Dec 17 Dec 16
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 12.38M 12.38M 12.38M 12.38M 12.38M 12.38M
Cash burn (monthly) (positive/no burn) (positive/no burn) 2.28M 2.95M 2.04M 1.65M
Cash used (since last report) n/a n/a 14.6M 18.87M 13.04M 10.54M
Cash remaining n/a n/a -2.22M -6.49M -665.9K 1.84M
Runway (months of cash) n/a n/a -1.0 -2.2 -0.3 1.1

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
21 Feb 21 Hopkins Robert O Common Stock Option exercise Aquire M No No 0 22,258 0 277,067
21 Feb 21 Hopkins Robert O RSU Common Stock Option exercise Dispose M No No 0 22,258 0 0
21 Feb 21 Marguglio David J. Common Stock Option exercise Aquire M No No 0 22,258 0 309,522
21 Feb 21 Marguglio David J. RSU Common Stock Option exercise Dispose M No No 0 22,258 0 0
21 Feb 21 Moss Ronald B. Common Stock Option exercise Aquire M No No 0 13,911 0 245,663
21 Feb 21 Moss Ronald B. RSU Common Stock Option exercise Dispose M No No 0 13,911 0 0
21 Feb 21 Carlo Dennis J PHD Common Stock Option exercise Aquire M No No 0 27,822 0 344,227
21 Feb 21 Carlo Dennis J PHD RSU Common Stock Option exercise Dispose M No No 0 27,822 0 0
21 Feb 20 Carlo Dennis J PHD Common Stock Option exercise Dispose M No No 0 27,823 0 316,405
21 Feb 20 Carlo Dennis J PHD RSU Common Stock Option exercise Dispose M No No 0 27,823 0 27,822

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change

Financial report summary

?
Competition
Glaxosmithkline
Management Discussion
  • Our consolidated results of operations are presented for the year ending December 31, 2019 and for the year ending December 31, 2018. 
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: asterisk, catalog, Conference, creation, DFSA, embedded, EPS, filer, FUTSA, GAAP, immune, inflammatory, judge, magistrate, mediation, pharmacokinetic, presiding, radiation, Recommendation, recommended, recommending, repaid, Stanford, Subtopic, triable, University, vet
Removed: billion, designated, niche, subset